620 results on '"Vonk, M"'
Search Results
2. Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertension
3. AB1176 SCOPING REVIEW TO GUIDE THE DEVELOPMENT OF AN ARTICULAR SCORE IN SYSTEMIC SCLEROSIS (ASSESS SCORE)
4. POS0822 ASSOCIATION BETWEEN NAILFOLD CAPILLAROSCOPIC PATTERN AND INCIDENT INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: A EUSTAR DATABASE ANALYSIS
5. POS0235 NEW ONSET OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: CLINICAL COURSE AND OUTCOMES FROM A EUSTAR DATABASE ANALYSIS
6. POS0230 CHARACTERISTICS AND DISEASE COURSE OF SSc-ILD PATIENTS WITH GASTROESOPHAGEAL REFLUX – AN ANALYSIS OF THE EUSTAR COHORT
7. POS0832 IMMUNOSUPPRESSION VERSUS COMBINATION OF IMMUNOSUPPRESSION AND ORAL GLUCOCORTICOIDS FOR SKIN FIBROSIS IN EARLY DIFFUSE SYSTEMIC SCLEROSIS PATIENTS. A TARGET TRIAL EMULATION STUDY FROM THE EUSTAR DATABASE
8. OP0225 CHANGES IN TREATMENT PATTERNS AND THEIR INFLUENCE ON THE OUTCOME OF SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE (SSc-ILD) PATIENTS: AN EUSTAR ANALYSIS
9. POS0839 DecreaSSc: AN OBSERVATIONAL STUDY TO ASSESS THE VALIDITY OF HOME MONITORING TO DETECT PROGRESSION OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS
10. OP0013 ANTI-Ro/SSA ANTIBODIES ARE PREDICTIVE OF A MORE SEVERE LUNG INVOLVEMENT IN PATIENTS WITH SYSTEMIC SCLEROSIS: A STUDY FROM THE EUSTAR HDATABASE
11. How to Assess a Patient for HSCT
12. Analysis of carbon monoxied absorption at z=2.5 to constrain variation of the proton-to-electron mass ratio
13. Dietary habits and compliance with dietary guidelines in patients with established cardiovascular disease.
14. Correction: Health-related quality-of-life trajectories during/after surgery and adjuvant chemotherapy in patients with colon cancer
15. Osteoporose
16. Study objectives in clinical trials in older patients with solid malignancies: do we measure what matters?
17. Intestinal hypomotility in systemic sclerosis: a histological study into the sequence of events
18. Prognostic value of screening instrument based on the Dutch national VMS guidelines for older patients in the emergency department
19. Sex differences in modifiable risk factors for stroke incidence and recurrence: the UCC-SMART study.
20. Traitement continu par nintedanib chez des patients présentant une pneumopathie interstitielle diffuse associée à la sclérodermie systémique (PID-ScS) : données à trois ans de SENSCIS-ON
21. The outcome of pulmonary hypertension and its association with pulmonary artery dilatation
22. The association between chronic kidney disease, falls, and fractures: a systematic review and meta-analysis
23. Development and Initial Validation of the Transracial Adoption Parenting Scale-Revised
24. How to Assess a Patient for HSCT
25. A path analysis of a cultural and racial socialization model in international transracial adoption: Racial awareness, self-efficacy, and socialization practices
26. The NS five-brane partition sum
27. String networks and supersheets
28. Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer
29. EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research
30. On the partition sum of the NS five-brane
31. Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function
32. POS1188-HPR EXPERIENCES OF TELEMONITORING PULMONARY FUNCTION IN SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE – A QUALITATIVE STUDY
33. OP0234 2023 UPDATE OF EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS
34. OP0276-HPR DAY-TO-DAY FLUCTUATIONS OF FATIGUE IN SYSTEMIC SCLEROSIS
35. OP0112 EXPANSION OF ACTIVATED CD7+ CYTOTOXIC T CELLS AND NK CELLS IN SSC AND PREVENTION OF FIBROBLAST CONTRACTION THROUGH SELECTIVE IMMUNOTOXIN-MEDIATED DEPLETION OF THESE CELLS
36. POS1255 CLINICAL SIGNIFICANCE OF THE ANTI-NUCLEOLAR ORGANIZER REGION 90 ANTIBODIES (NOR90) IN SYSTEMIC SCLEROSIS: A EUROPEAN SCLERODERMA TRIALS AND RESEARCH (EUSTAR) ANALYSIS
37. OP0239 DOES EARLY IMMUNOSUPPRESSIVE THERAPY PREVENT SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE?
38. AB0152 URIC ACID IN SYSTEMIC SCLEROSIS-RELATED PULMONARY ARTERIAL HYPERTENSION:INNOCENT BYSTANDER OR COVERT ACCOMPLICE?
39. POS0126 CONTINUED TREATMENT WITH NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD): THREE-YEAR DATA FROM SENSCIS-ON
40. Contextual determinants influencing the implementation of fall prevention in the community: a scoping review
41. TGFβ-mediated expression of TGFβ-activating integrins in SSc monocytes: disturbed activation of latent TGFβ?
42. Reply to comment on “Sarcopenia is a prognostic factor for overall survival in elderly patients with head and neck cancer”
43. A comprehensive fracture prevention strategy in older adults: The European union geriatric medicine society (EUGMS) statement
44. Links between Atherosclerosis and Osteoporosis in Middle Aged and Elderly Men
45. Peripheral microvascular function is linked to cardiac involvement on CMR in systemic sclerosis-related pulmonary arterial hypertension patients
46. MSW Students' Attitudes toward Transracial Adoption
47. Development and Initial Validation of the Intimate Violence Responsibility Scale (IVRS)
48. POS0854 BASELINE CHARACTERISTICS OF PATIENTS WITH IMPROVEMENT OR PROGRESSION OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSc-ILD) DURING THE SENSCIS TRIAL
49. AB0139 DEEP IMMUNE PHENOTYPING OF T LYMPHOCYTE SUBSETS IN SYSTEMIC SCLEROSIS PATHOPHYSIOLOGY AND FOLLOWING RESPONSE TO TARGETED CYTOTOXIC TREATMENT
50. POS0388 DEVELOPING A SCREENING TOOL FOR THE DETECTION OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: THE ILD-RISC RISK SCORE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.